-
Pfizer
- Sales Manager, Anti-Infectives
Paris
2015 - maintenant
Main missions:
Management of 10 hospital reps. Leadership Management. 1st region in sales (€36M in 2016).
Key achievements:
- Loss of Exclusivity management for 2 products: alternative communications development; work on products positioning in hospitals therapeutic strategies
- Responsible for coordinating the integration of AstraZeneca's anti-infective portfolio
- Launch of a new product: Market definition; coordination of targeting update for the entire AI network; development of a patient flow model, work on product referencing
-
Pfizer
- Director of Business Operations & Chief of staff (BU Global Innovative Pharma)
Paris
2015 - 2015
8 months secondment (maternity leave replacement).
Main missions:
-Lead of Operational Effectiveness Department (20 positions) comprising Digital, Events and Meetings, Compliance, Customers Planning and Commercial Development
- Member and Chief of Staff B.U. Leadership Team (LT; Executive Committee): Organization, animation, coordination and follow-up of BU LT decisions
- Transversal projects lead, especially at European level
Key Achievements:
- Coordination of European Business Review and Operating Plan 2016
- Coordination of aTasking work and B.U. restructuring, with HR and Finance
- Review and validation of the BU Digital Plan
-
Pfizer
- Sales Manager, Established Products Portfolio
Paris
2014 - 2015
Main missions:
Management of a "geolocalized" structure of 12 reps / 3 fields networks (2 hospital reps, 7 Retail and Pharmacy reps and 3 Pharmacy reps): Definition and implementation of operational strategies for the Established Products portfolio in my area. 2014 sales = € 12.9M.
Key Achievements:
- Definition of area-specific incentive protocol relevant with the area strategy
- Mentoring of 2 junior sales managers
- "Dare To Try Superchampion": definition and implementation for France of a global enterprise project promoting innovation. Training and animation of a 30 champions community
-
Pfizer
- Sales Manager, Pharmacy
Paris
2013 - 2014
Main missions:
- Management of 9 Pharmacy reps. 1st region in France (€9.5M in 2013).
- Implementation of Pfizer Generics and princeps Direct Sales strategy
Key Achievements:
- Coaching on self-confidence and valorization of business attempts: 3 reps in Top 10 at the beginning of 2013; 5 at mid-2014
- Development of my team and of their employability: 4 commercial reps have passed a diploma validating their know-how and their experience, then 2 could become medical reps in 2015
-
Pfizer
- Country Brand Lead, Anti-Infectives France
Paris
2012 - 2013
Main missions:
- Within the European team, responsible for all antifungal marketing activities in France
- Development and coordination of brand plans and media plans
- Market Analysis and Competitive Intelligence. Monitoring of the PnL and budget
Key Achievements:
- Full revision of the Qualification / Segmentation / Targeting, including a KOL mapping
- Definition and coordination of a product shortage management
-
Pfizer
- Overseas Sales Coordinator, Specialty Care B.U.
Paris
2012 - 2013
Main missions:
- Coordination and animation of the 6 overseas reps for the Specialty Care B.U. products
- Definition of workplans and training plans.
- Review of reps action plans.
Key Achievements:
- Reps meetings organization
- Definition of sales objectives and incentive protocols
- Assessment of reps performance
-
Pfizer
- Country Brand Lead Xiapex (product launch)
Paris
2010 - 2012
Main missions:
- Within the European team, responsible for all marketing activities in France regarding Xiapex launch in the Dupuytren Disease. Team leader of the France project team (12 people).
- Conception of strategic and tactical plans.
Key Achievements:
- Work on market access. Preparation of the Risk Management Plan
- Identification of KOLs, organization and animation of 2 advisory boards (rheumatology and surgery)
- Segmentation, targeting and positioning. Definition of PnL. Definition of the Sales Force
- Award Top Performer 2010
-
Wyeth
- Rheumatology Marketing Team Manager
2007 - 2010
Enbrel (etanercept), € 237M in 2010.
Main missions:
- Responsible for the "Rheumatoid Arthritis" marketing team (60% of total sales). Management of 2 product managers
- France Lead on the European team
- Responsible for Brand plans in Rheumatology
Key Achievements:
- Optimization of differentiating communication and publication plans in France
- Reorganization of the Rheumatology Medical Education events (Quanti and Quali): in 2007, 70/100 attendees; In 2010, 332/300 (with only 2% no-show and verified target values)
- Implementation of a KOL mapping; advisory boards animation
-
Wyeth
- Marketing Manager, GPs ans Patients Associations Groups
2007 - 2007
Main missions:
- Definition and implementation of the GPs communication strategy
- Animation of relationship with patients associations groups
Key achievements:
- Implementation of an online training program for GPs in rheumatology
- Market extension: + 15% of patients sent to rheumatologists by GPs (March to Oct)
- Implementation of 14 information meetings for Patients, in coordination with AFP and ANDAR associations
-
Bristol-Myers Squibb
- Antihypertensive Products Manager
Rueil-Malmaison cedex
2003 - 2007
Aprovel and CoAprovel: Leader of antihypertensive drugs in France; € 206M in 2006. BMS and Sanofi co-promotion.
Main missions:
- Marketing Manager for Retail Operations / General Practitioners
- Animation of relationship with sales reps (4 internal networks + 2 external networks)
Key Achievements:
- Organization of innovative training meetings in France and Europe: + 25% attendance in 2005. 3 meetings of 200 GPs each in 2006
- Development and launch of a public health program for patients (press, radio, posters, leaflets): "Action on my Tension"
-
Bristol-Myers Squibb
- Pain Products Manager
Rueil-Malmaison cedex
2002 - 2003
Opioids portfolio (€ 24M) then Perfalgan (€ 38M)
Main missions:
- Launch of Perfalgan, 1st injectable acetaminophen
- Development of brand campaigns and coordination of sales reps relationships
Key Achievements:
- Conducting surveys for hospital prescribers and pharmacists
- Development of a national protocolization program with a advisory board
